US88025U1097
© PR Newswire
12.01.2026
TXG
LISTED
NASDAQ
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
News Preview
Study aims to identify single cell immune signatures of disease activity and treatment response to support clinical care PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women's Hospital, a world-class academic medical...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
TXG
LISTED
NASDAQ
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
News Preview
Collaboration with Dana-Farber Cancer Institute aims to identify biomarkers linked to treatment response for the next generation of cancer therapies and to define a clinical reporting framework to power precision oncology10x also plans to establish a CLIA-certified laboratory to enable development of future innovative diagnostic testsPLEASANTON, C...
Themefolio
Profiler
Peergroup
© PR Newswire
12.01.2026
TXG
LISTED
NASDAQ
Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology
News Preview
Multi-phase initiative will generate single cell and spatial data from over 20,000 samples across leading immuno-oncology laboratories to map the immune landscape of cancer and drive the next generation of immunotherapies and vaccine discovery PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single ce...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
11.01.2026
TXG
LISTED
NASDAQ
10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results
News Preview
PLEASANTON, Calif., Jan. 11, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select results for the fourth quarter and full year ended December 31, 2025....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
29.12.2025
TXG
LISTED
NASDAQ
10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 a.m. Pacific Time....
Themefolio
Profiler
Peergroup
© PR Newswire
18.11.2025
TXG
LISTED
NASDAQ
New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium
News Preview
Initiative led by researchers in Australia and Japan aims to map cancer and immune interactions to advance precision oncology across the region
PLEASANTON, Calif. and SYDNEY, Nov. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
TXG
LISTED
NASDAQ
10x Genomics Reports Third Quarter 2025 Financial Results
News Preview
PLEASANTON, Calif., Nov. 6, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
TXG
LISTED
NASDAQ
10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research
News Preview
New plate-based multiplexing unlocks ultra high-sample and cell-throughput single cell analysis to empower a broad range of studies
PLEASANTON, Calif., Oct. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology,...
Themefolio
Profiler
Peergroup
© PR Newswire
20.10.2025
TXG
LISTED
NASDAQ
10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences
News Preview
Collaboration enables researchers to begin exploring 10x single cell tools and datasets conversationally, with spatial applications to follow - making advanced analysis more accessible to the broader researcher community
PLEASANTON, Calif., Oct. 20, 2025 /PRNew...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2025
TXG
LISTED
NASDAQ
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
PLEASANTON, Calif., Oct. 9, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the third quarter ended September 30, 2025 after market close on Thursday, November 6, 2025. The company will host a public conference call...
Themefolio
Profiler
Peergroup
© PR Newswire
09.09.2025
TXG
LISTED
NASDAQ
CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics
News Preview
Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path for Blood Disorder Diagnosis, complementing bone marrow procedures
PLEASANTON, Calif. and REHOVOT, Israel, Sept. 9, 2025 /PRNewswire/ -- CLISEQ Ltd., a translational diagnostics company spun out of Yeda, the comme...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
TXG
LISTED
NASDAQ
10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
News Preview
PLEASANTON, Calif., Aug. 27, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on Wednesday, September 10, at 11:30 a.m. Eastern Time. ...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
19.08.2025
TXG
LISTED
NASDAQ
10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis
News Preview
First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deeper insights into cell function and disease biology
PLEASANTON, Calif., Aug. 19, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Xenium Prote...
Themefolio
Profiler
Peergroup
© PR Newswire
07.08.2025
TXG
LISTED
NASDAQ
10x Genomics Reports Second Quarter 2025 Financial Results
News Preview
PLEASANTON, Calif., Aug. 7, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended June 30, 2025.
Recent Updates
Revenue wa...
Themefolio
Profiler
Peergroup
© PR Newswire
07.08.2025
TXG
LISTED
NASDAQ
10x Genomics to Acquire Scale Biosciences
News Preview
Acquisition Will Further Expand Chromium's Capabilities
PLEASANTON, Calif., Aug. 7, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has signed a definitive agreement to acquire Scale Biosciences, Inc., a leader in innovative and scalable single cell analysis. The acquisit...
Themefolio
Profiler
Peergroup
© PR Newswire
17.07.2025
TXG
LISTED
NASDAQ
10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery
News Preview
Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases
PLEASANTON, Calif. and SINGAPORE, July 17, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore (A*STAR GIS), t...
Themefolio
Profiler
Peergroup
© PR Newswire
10.07.2025
TXG
LISTED
NASDAQ
10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025
News Preview
PLEASANTON, Calif., July 10, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the second quarter ended June 30, 2025 after market close on Thursday, August 7, 2025. The company will host a public conference call and live webcast for analysts and inve...
Themefolio
Profiler
Peergroup
© PR Newswire
14.05.2025
TXG
LISTED
NASDAQ
10x Genomics Announces Patent Litigation Settlement Agreement with Bruker
News Preview
PLEASANTON, Calif., May 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has reached a settlement agreement with Bruker Corporation, successfully resolving all outstanding worldwide patent litigation and disputes between the two companies. As part of the settlement, 10...
Themefolio
Profiler
Peergroup
© PR Newswire
08.05.2025
TXG
LISTED
NASDAQ
10x Genomics Reports First Quarter 2025 Financial Results
News Preview
PLEASANTON, Calif., May 8, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31, 2025.
Recent Updates
Revenue was...
Themefolio
Profiler
Peergroup
© PR Newswire
30.04.2025
TXG
LISTED
NASDAQ
10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference
News Preview
PLEASANTON, Calif., April 30, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the BofA Securities 2025 Healthcare Conference on Tuesday, May 13, at 11:20 a.m. Pacific Time....
Themefolio
Profiler
Peergroup
© PR Newswire
14.04.2025
TXG
LISTED
NASDAQ
10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025
News Preview
PLEASANTON, Calif., April 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the first quarter ended March 31, 2025 after market close on Thursday, May 8, 2025. The company will host a public conference call and live webcast for analysts and invest...
Themefolio
Profiler
Peergroup
© PR Newswire
03.03.2025
TXG
LISTED
NASDAQ
10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products
News Preview
10x Genomics' ATAC-Seq patents found valid and infringed
PLEASANTON, Calif., March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, 2025, in the United States District Court...
Themefolio
Profiler
Peergroup
© PR Newswire
23.02.2025
TXG
LISTED
NASDAQ
10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis
News Preview
New single cell and spatial innovations extend 10x Genomics' technology and performanceleadership across all three platforms
PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced a series of...
Themefolio
Profiler
Peergroup
© PR Newswire
18.02.2025
TXG
LISTED
NASDAQ
10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference
News Preview
PLEASANTON, Calif., Feb. 18, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, at 11:10 a.m. Eastern Time....
Themefolio
Profiler
Peergroup
© PR Newswire
12.02.2025
TXG
LISTED
NASDAQ
10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025
News Preview
PLEASANTON, Calif., Feb. 12, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the fourth quarter and full year ended December 31, 2024 and provided outlook for 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
06.02.2025
TXG
LISTED
NASDAQ
Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology
News Preview
Landmark single-cell dataset of one billion cells will be used to train new AI models to advance researchers' understanding of cellular behavior and gene function
REDWOOD CITY, Calif. , Feb. 6, 2025 /PRNewswire/ -- Today, the Chan Zuckerberg Initiative (CZI) launched the Billion Cells Project, an effort to generate an unprecedented one billion ce...
Themefolio
Profiler
Peergroup
© PR Newswire
28.01.2025
TXG
LISTED
NASDAQ
10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025
News Preview
PLEASANTON, Calif., Jan. 28, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the fourth quarter and full year ended December 31, 2024 after market close on Wednesday, February 12, 2025. The company will host a public conference call and live webcast...
Themefolio
Profiler
Peergroup
© PR Newswire
02.01.2025
TXG
LISTED
NASDAQ
10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
News Preview
PLEASANTON, Calif., Jan. 2, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 7:30 a.m. Pacific Time....
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2024
TXG
LISTED
NASDAQ
10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference
News Preview
PLEASANTON, Calif., Nov. 7, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the Wolfe Research 2024 Healthcare Conference on Tuesday, November 19, at 1:00 p.m. Eastern Time....
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2024
TXG
LISTED
NASDAQ
TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative
News Preview
Cure51 plans to analyze more than 1,000 tumor samples from exceptional cancer survivors
PARIS and PLEASANTON, Calif., Oct. 31, 2024 /PRNewswire/ -- French TechBio startup Cure51 and 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that Cure51 will deploy 10x Genomics' Visium HD as part of its pioneeri...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2024
TXG
LISTED
NASDAQ
10x Genomics Reports Third Quarter 2024 Financial Results
News Preview
PLEASANTON, Calif., Oct. 29, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September 30, 2024.
Recent Highlights
Rev...
Themefolio
Profiler
Peergroup
© PR Newswire
15.10.2024
TXG
LISTED
NASDAQ
10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches
News Preview
PLEASANTON, Calif., Oct. 15, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products intended to democratize access to single cell analysis. The new offerings – GEM-X Flex and GEM-X Universal Multiplex – introduce significant improvements in perfor...
Themefolio
Profiler
Peergroup
© PR Newswire
09.10.2024
TXG
LISTED
NASDAQ
10x Genomics Announces Preliminary Select Third Quarter 2024 Results
News Preview
PLEASANTON, Calif., Oct. 9, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary select results for the third quarter ended September 30, 2024.
Preliminary...
Themefolio
Profiler
Peergroup
© PR Newswire
01.10.2024
TXG
LISTED
NASDAQ
10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting
News Preview
PLEASANTON, Calif., Oct. 1, 2024 /PRNewswire/ -- At the Human Cell Atlas General Meeting held September 29-30 in Milan, Italy, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, shared new details about its upcoming product roadmap and its ongoing strategy to democratize access to single cell analysis....
Themefolio
Profiler
Peergroup
© PR Newswire
03.09.2024
TXG
LISTED
NASDAQ
10x Genomics Unveils Chromium Xo: A Low-Cost Instrument to Expand Access to High-Performance Single Cell Research
News Preview
PLEASANTON, Calif., Sept. 3, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced the launch of Chromium Xo, a new addition to its fleet of Chromium single cell instruments. Designed to meet the needs of researchers who desire high-quality data on limited budgets, Chromium Xo offers a...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2024
TXG
LISTED
NASDAQ
10x Genomics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
News Preview
PLEASANTON, Calif., Aug. 22, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, at 10:45 a.m. Eastern Time....
Themefolio
Profiler
Peergroup
© PR Newswire
08.08.2024
TXG
LISTED
NASDAQ
10x Genomics Announces Senior Leadership Changes
News Preview
PLEASANTON, Calif., Aug. 8, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today several changes to its executive team.
Mennah Moustafa has been named Chief Commercial...
Themefolio
Profiler
Peergroup
© PR Newswire
08.08.2024
TXG
LISTED
NASDAQ
10x Genomics Reports Second Quarter 2024 Financial Results
News Preview
PLEASANTON, Calif. , Aug. 8, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended June 30, 2024.
Recent Highlights
Revenue...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
